Skip to main content
. 2015 Aug 21;16(5):986–995. doi: 10.3348/kjr.2015.16.5.986

Fig. 2. Kaplan-Meier curves for survival in each breast cancer molecular subtype.

Fig. 2

Radiologic assessment in triple-negative breast cancer (A), HER2-positive breast cancer (B), and ER-positive breast cancer (C). Pathologic assessment in triple-negative breast cancer (D), HER2-positive breast cancer (E), and ER-positive breast cancer (F). CR = complete response, ER = estrogen receptor, HER2 = human epidermal growth factor receptor 2